On June 23, 2025, the Court of Appeals for the Ninth Circuit issued a decision holding that qui tam relators may pursue False Claims Act cases alleging customs fraud in United States District Courts even though the Court of International Trade (“CIT”) also affords the government a forum for recovering unpaid customs duties. See United . . .
Read More from Ninth Circuit Removes Cloud Over Qui Tam Cases Alleging Customs Fraud
On May 1, 2025, the Department of Justice filed a complaint in intervention in a qui tam case that Gregg Shapiro filed in 2021 on behalf of a whistleblower client against several of the nation’s largest Medicare Advantage insurance carriers and brokers. A copy of the government’s complaint is here, and a copy of the . . .
In a statement of interest (“SOI”) that it filed today in United States ex rel. Witkin v. Medtronic, Inc., No. 11-cv-10790-IT (D. Mass.), the United States reiterated its view that it need not prove but-for causation in a False Claims Act (“FCA”) case predicated on a false certification of compliance with the anti-kickback statute (“AKS”), . . .
In a recent decision, Omni Healthcare, Inc. v. MD Spine Solutions LLC (D. Mass. Jan. 6, 2025), the court held that the relator needed to show but-for causation in a False Claims Act case predicated on alleged violations of the anti-kickback statute. The anti-kickback statute provides that “a claim that includes items or services resulting . . .
On November 15, 2024, the United States Attorney’s Office for the District of Massachusetts announced that QOL Medical and its CEO, Frederick E. Cooper, agreed to pay $47 million to resolve allegations that they caused the submission of false claims to federal health care programs by offering kickbacks, in the form of free Carbon-13 breath . . .
On July 17, 2024, the Department of Justice announced that Kindred at Home, a hospice company, agreed to pay $19.428 million to resolve False Claims Act allegations that Kindred “knowingly submitted false claims and knowingly retained overpayments for hospice services provided to patients who were ineligible to receive hospice benefits under various federal health care . . .
On May 16, 2024, the Department of Justice announced that it had reached a $24.4 million settlement with Cape Cod Hospital (CCH) to resolve allegations that Gregg Shapiro’s whistleblower client, a former physician at the hospital, had filed in a False Claims Act qui tam complaint. The whistleblower alleged that CCH had violated the False . . .
On December 21, 2023, the government announced that Ultragenyx Pharmaceutical Inc. (Ultragenyx) has agreed to pay $6 million to settle a False Claims Act qui tam case that Gregg Shapiro filed in 2021 on behalf of a whistleblower who was then working at Ultragenyx. The whistleblower alleged that Ultragenyx used kickbacks to generate sales of . . .
On October 27, 2023, in a declined District of Massachusetts qui tam case called United States ex rel. Witkin v. Medtronic, Inc., the Department of Justice (“DOJ”) filed a sweeping statement of interest on the proper causation standard in False Claims Act (“FCA”) cases predicated on violations of the anti-kickback statute (“AKS”), as well as . . .
On July 26, 2023, the Department of Justice announced that it had reached a settlement for $217,832 with bean bag furniture maker Yogibo, LLC, in a customs fraud False Claims Act qui tam action that we initiated last year on behalf of our client, the former Warehouse Manager at a Yogibo facility in Nashua, New . . .
Read More from Yogibo Agrees to Pay Over $217K to Resolve Customs Fraud Allegations